Abstract: A device (1) for introducing endovascular implants (3), which have an at least partially cylindrical design, into blood vessels, where the implant (3) is provided in an expanded state in which the implant is placed in the blood vessel, and in a compressed state, in which the implant can be introduced into the blood vessel, and the device (1) has an elongated shaft (2), the exterior of which is releasably secured to the implant (3) in the compressed state and through which the implant (3) runs.

Abstract: A substantially tubular structure with a plurality of mesh cells (3, 4) composed of struts, with two connecting struts (5, 5?), disposed at proximal mesh cells at the proximal end of the tubular structure (1) and extending in proximal direction, and being provided with a coupling member (11) disposed proximally of the tubular structure (1) with the connecting struts (5, 5?) being connected to said member, wherein the coupling member (11) being connected to a pusher/insertion wire, and wherein struts of the proximal mesh cells, the connecting struts (5, 5?), and the coupling member (11) as well as bracing struts (9) that may be arranged between the proximal mesh cells form a closed, annular structure (6), and the annular structure (6) comprising a ring marker (12) with a radiopaque material for identifying the spatial position of the annular structure (6).

Abstract: A device (1) with a stent structure (2) wherein the stent structure (2), preferably at its proximal end, is connected to an insertion aid (3), and wherein the device (1) is deployable for the treatment of a vasospasm and the stent structure (2) is designed so as to be detachable from the insertion aid (3), with at least portions of the stent structure (2) being provided with a coating and this coating comprising a functional layer, with said functional layer containing at least one sugar alcohol and/or being formed by an oligo- or polymerization of monosaccharides functionalized with polymerizable groups. Furthermore, the invention also relates to a relevant method for the treatment of vasospasms.

Abstract: A device for introducing an implant (1) into blood vessels or hollow organs of the human or animal body. The device includes an implant (1), an insertion wire (14) and a release tube (13), wherein the implant (1) is deformable so that it fits into a microcatheter (8) and expands once the external constraint of the microcatheter (8) disappears, adapting to the diameter of the blood vessel or hollow organ, wherein a holding element (2) is arranged on the insertion wire (14) and the holding element (2) has at its periphery at least one groove (3) set into the holding element (2), running along the circumference of the holding element (2) and forming tracks in the form of curved lines, wherein the implant (1) has holding wired (5) extending proximally, which are fitted into the grooves (3).

Abstract: A device for introducing an implant (1) into blood vessels or hollow organs of the human or animal body. The device includes an implant (1), an insertion wire (14) and a release tube (13), wherein the implant (1) is deformable so that it fits into a microcatheter (8) and expands once the external constraint of the microcatheter (8) disappears, adapting to the diameter of the blood vessel or hollow organ, wherein a holding element (2) is arranged on the insertion wire (14) and the holding element (2) has at its periphery at least one groove (3) set into the holding element (2), running along the circumference of the holding element (2) and forming tracks in the form of curved lines, wherein the implant (1) has holding wired (5) extending proximally, which are fitted into the grooves (3).

Abstract: A medical device substrate with a coating including a functional layer located on the substrate, with the functional layer including at least one sugar alcohol and being bonded to the substrate directly or indirectly via a functionalization of the sugar alcohol. Alternatively, the functional layer may also include other saccharides, in which case it is essential that polymerization of the saccharides takes place only upon bonding to the substrate. The inventive medical device exhibits reduced platelet adhesion and aggregation.

Abstract: An implant (6, 18) for influencing the flow of blood in the area of bifurcation aneurysms with the implant (6, 18) having a first (1, 14) and a second tubular braided section (2, 15) each having an opening (4, 5, 16, 17) in the wall, wherein the openings (4, 5, 16, 17) in the walls being produced in such a way that the wires (3) forming the braided sections (1, 2, 14, 15) are radially displaced at the positions of the openings (4, 5, 16, 17), and the first braided section (1, 14) is guided through the opening (5, 17) in the wall of the second braided section (2, 15) such that the opening (4, 16) in the wall of the first braided section (1, 14) points to the opening (5, 17) in the wall of the second braided section (2, 15).

Abstract: The invention relates to an insertion system for an implant (1) for influencing the blood flow in the region of aneurysms (22) located at vascular bifurcations. The implant (1) has two distal tubular implant portions (2) which are intended to be placed in blood vessels (21) branching off from the stem blood vessel (20) and which are connected to one another at a branching point (4). The insertion system has two sleeves (5) which are each designed to hold a distal tubular implant portion (2). The two sleeves (5) each have a distal sleeve portion (6) and the distal sleeve portions (6) each have an opening zone (7) extending in the longitudinal direction. The distal sleeve portions (6) are each adjoined proximally by a proximal portion (8), by means of which the sleeves (5) can be retracted in the proximal direction so that the opening zones (7) open and the distal tubular implant portions (2) each pass through the opening zones (7) and are released into the branching blood vessels (21).

Abstract: An implant (1) for the treatment of arteriovenous deformities, in particular aneurysms (2). In an expanded state the implant has a basic body (6) comprising of a proximal and a distal segment (7, 8), with the proximal and the distal segment (7, 8) being of dome-shaped configuration, with the convex side of the dome of the proximal segment (7) facing in the proximal direction and the convex side of the dome of the distal segment (8) facing in the distal direction, and wherein the proximal and the distal segment (7, 8) are connected to each other via a plurality of connecting struts (9). Alternatively, the implant (1) may have the shape of a closed tulip blossom. The inventive implant (1) is able to adapt well to the shape of the respective aneurysm (2).

Abstract: An implant (1) for the treatment of aneurysms (11), wherein the implant (1) has an elongated configuration navigable via a microcatheter (12) and a secondary configuration which it assumes upon release from the microcatheter (12). The implant (1) forms an open, unrolled structure (2) extending from proximal to distal, said implant being built up of a plurality of struts (3) forming adjacent cells (4), and with at least a part of said cells (4) being provided with membranes (6) filling the cells (4), and with the secondary structure comprising an at least partial rolling up of the open, unrolled structure (2) axially and radially relative to the longitudinal axis of the implant (1) and resulting in the formation of a spherical structure. The implant (1) proposed by the invention is suitable to adapt to the inner wall of an aneurysm (11) and to fill an aneurysm (11) almost completely.

Abstract: A medical having a proximal and a distal end, that is preformed to assume a superimposed structure at an implantation site but can be made to take on a volume-reduced form making it possible to introduce it by means of a micro-catheter and a guide wire arranged at the proximal end, with the implant in its superimposed structure assuming the form of a longitudinally open tube and having a mesh structure of interconnected strings or filaments. The implant has a tapering structure at its proximal end where the strings or filaments converge at a connection point.

Abstract: The invention relates to a device (1) having a stent structure (2) intended for the insertion into blood vessels of the human or animal body, wherein the stent structure (2) assumes an expanded state during which it is in contact with the inner wall of the blood vessel and a contracted state during which the stent structure being located in a microcatheter can be moved through the blood vessel, wherein the stent structure (2) preferably being connected at its proximal end with an delivery wire (3) and wherein the device (1) being employed for the treatment of vasospasm. Moreover, the invention also relates to a relevant method for the treatment of vasospasm.

Abstract: A device for introducing an implant (1) into blood vessels or hollow organs of the human or animal body. The device includes an implant (1), an insertion wire (14) and a release tube (13), wherein the implant (1) is deformable so that it fits into a microcatheter (8) and expands once the external constraint of the microcatheter (8) disappears, adapting to the diameter of the blood vessel or hollow organ, wherein a holding element (2) is arranged on the insertion wire (14) and the holding element (2) has at its periphery at least one groove (3) set into the holding element (2), running along the circumference of the holding element (2) and forming tracks in the form of curved lines, wherein the implant (1) has holding wired (5) extending proximally, which are fitted into the grooves (3).

Abstract: The invention relates to an implant for vascular applications that can be transported by means of a catheter and is intended in particular to influence the blood flow in the area of arteriovenous malformations, such as fistulas and aneurysms, to fill the saclike dilation of the malformation, promote thrombus formation and cover the neck of the malformation. The implant according to the invention is provided with an occlusion unit (1, 13) having a three-dimensional shape constructed from several subunits (5a, 14) from a framework of struts (5, 16, 17), with a covering, preferably a membrane (6), being located between struts (5, 16, 17).

Abstract: An occlusive implant for bifurcation aneurysms (A), with the implant (1) being in an expanded state in which it is implanted in the blood vessel and in a contracted state in which it is movable through the blood vessel, with the implant (1) having a proximal fixing section (3) by means of which the implant (1) can be secured to the wall of a blood vessel, a distal section (5) where the implant (1) in expanded state is radially widened relative to the fixing section (3) and which is intended for placement in or in front of the aneurysm (A), and having a transition section (4) located between the fixing section (3) and the distal section (5), wherein fixing section (3) is attached to an delivery wire (2) in a detachable manner and wherein the transition section (4) has a second detachment point (7) which enables the distal section (5) to be detached.

Abstract: A device for introducing an implant (1) into blood vessels or hollow organs of the human or animal body. The device includes an implant (1), an insertion wire (14) and a release tube (13), wherein the implant (1) is deformable so that it fits into a microcatheter (8) and expands once the external constraint of the microcatheter (8) disappears, adapting to the diameter of the blood vessel or hollow organ, wherein a holding element (2) is arranged on the insertion wire (14) and the holding element (2) has at its periphery at least one groove (3) set into the holding element (2), running along the circumference of the holding element (2) and forming tracks in the form of curved lines, wherein the implant (1) has holding wired (5) extending proximally, which are fitted into the grooves (3).

Abstract: A device (1) for introducing endovascular implants (3), which have an at least partially cylindrical design, into blood vessels, where the implant (3) is provided in an expanded state in which the implant is placed in the blood vessel, and in a compressed state, in which the implant can be introduced into the blood vessel, and the device (1) has an elongated shaft (2), the exterior of which is releasably secured to the implant (3) in the compressed state and through which the implant (3) runs.

Abstract: A device (1) for removing thrombi from blood vessels, wherein the device (1) has an expanded state in which it is set free temporarily in the blood vessel and a compressed state in which it is introduced into and removed from the blood vessel through a microcatheter, wherein the device (1) has a proximal (2), a middle (3) and a distal portion (4), with the middle portion (3) having a substantially cylindrical structure and the proximal portion (2) being coupled to an insertion aid (5), and the distal portion (4) having a substantially cylindrical basic structure, with a constriction (6) being arranged between the middle (3) and distal portion (4), and the distal portion (4) being at least partially covered by a membrane (7). The inventive device (1) is characterized by the fact that thrombus fragments becoming detached from the thrombus to be captured are safely retained and removed from the blood vessel.

Abstract: An implant (1) to be used for the occlusion of bifurcation aneurysms, with the implant (1) having an expanded state in which it is implanted in the blood vessel (Z) and a contracted state in which it is movable through the blood vessel (Z) and a proximal fixing section (3) a distal section (5) where the implant (1) is radially widened relative to the fixing section (3) and which is intended for placement in or in front of the aneurysm (A), and a transition section (4) located between the fixing section (3) and the distal section (5), wherein the implant (1). The implant is composed of interconnected or intersecting filaments (10) originating from the fixing section (3) or distal section (5) which meet centrally in the transition section (4), wherein the filaments (10) in the transition section (4) at least to some extent pass through a sleeve (7).

Abstract: A medical device substrate with a coating including a functional layer located on the substrate, with the functional layer including at least one sugar alcohol and being bonded to the substrate directly or indirectly via a functionalization of the sugar alcohol. Alternatively, the functional layer may also include other saccharides, in which case it is essential that polymerization of the saccharides takes place only upon bonding to the substrate. The inventive medical device exhibits reduced platelet adhesion and aggregation.